Effect of Fludrocortisone on Adrenoceptors and Free Intracellular Calcium in Man

[1]  M. Kuramochi,et al.  Effect of dietary sodium on platelet alpha 2-adrenergic receptors in essential hypertension. , 1985, Hypertension.

[2]  R. Webb,et al.  Cerebral Intraventricular 6-Hydroxydopamine Prevents Vascular Changes in the Mineralocorticoid Hypertensive Rat 1 , 1985, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[3]  J. Laragh,et al.  Calcium metabolism and parathyroid function in primary aldosteronism. , 1985, The American journal of medicine.

[4]  L. Krakoff,et al.  Reduced Sympathetic Neuronal Uptake (Uptake1) in a Genetic Model of Desoxycorticosterone-NaCl Hypertension 1 , 1985, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[5]  H. Motulsky,et al.  A hypothesis linking intracellular sodium, membrane receptors, and hypertension. , 1984, Life sciences.

[6]  R. Tsien,et al.  Cytoplasmic free Ca2+ in human platelets: Ca2+ thresholds and Ca‐independent activation for shape‐change and secretion , 1982, FEBS letters.

[7]  G. Wright,et al.  Concentrations of ionic and total calcium in plasma of four models of hypertension. , 1982, The American journal of physiology.

[8]  R Y Tsien,et al.  Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator , 1982, The Journal of cell biology.

[9]  J. Mooney,et al.  Sodium inhibits both adenylate cyclase and high-affinity 3H-labeled p-aminoclonidine binding to alpha 2-adrenergic receptors in purified human platelet membranes. , 1982, Molecular pharmacology.

[10]  A. W. Jones,et al.  Aldosterone Infusion into the Rat and Dose‐Dependent Changes in Blood Pressure and Arterial Ionic Transport , 1982, Hypertension.

[11]  A. J. Man in 't Veld,et al.  Time-course of vascular resistance changes in mineralocorticoid hypertension of man. , 1981, Clinical science.

[12]  T. Brock,et al.  Preand Postcapillary Vascular Responses to Sympathetic Nerve Stimulation in DOCA‐Hypertensive Dogs , 1981, Hypertension.

[13]  S. Yamada,et al.  Alterations in central and peripheral adrenergic receptors in deoxycorticosterone/salt hypertensive rats. , 1980, Life sciences.

[14]  C. Johnston,et al.  Reduced vascular beta-adrenergic receptors in deoxycorticosterone-salt hypertensive rats. , 1980, Biochemical pharmacology.

[15]  S. Oparil,et al.  Importance of Renal Sympathetic Tone in the Development of DOCA‐Salt Hypertension in the Rat , 1980, Hypertension.

[16]  C. Johnston,et al.  Decreased cardiac beta-adrenergic receptors in deoxycorticosterone-salt and renal hypertensive rats. , 1979, Circulation research.

[17]  S. Friedman,et al.  Evidence for enhanced Na transport in hypertension induced by DOCA in the rat. , 1978, Canadian journal of physiology and pharmacology.

[18]  H. W. Overbeck,et al.  Abnormal Ion and Water Composition of Veins and Normotensive Arteries in Coarctation Hypertension in Rats , 1976, Circulation research.

[19]  J. Reid,et al.  Central and Peripheral Adrenergic Mechanisms in the Development of Deoxycorticosterone‐Saline Hypertension in Rats , 1975, Circulation research.

[20]  E. Haber,et al.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. , 1969, The Journal of clinical endocrinology and metabolism.

[21]  R. Mueller,et al.  Turnover and synthesis of norepinephrine in experimental hypertension in rats. , 1969, Circulation research.

[22]  A. Chobanian,et al.  Body fluid and electrolyte composition in arterial hypertension. II. Studies in mineralocorticoid hypertension. , 1961, The Journal of clinical investigation.

[23]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[24]  C. Hall,et al.  Prevention of DOCA-salt hypertension with the calcium blocker nitrendipine. , 1983, Clinical and experimental hypertension. Part A, Theory and practice.

[25]  W. Oelkers,et al.  The effect of captopril on renin, angiotensin II, cortisol and aldosterone during ACTH-infusion in man. , 1982, Clinical and experimental hypertension. Part A, Theory and practice.

[26]  M. Lokhandwala,et al.  Impairment of neurally-mediated vasoconstriction in DOCA-salt hypertensive dogs. , 1982, Clinical and experimental hypertension. Part A, Theory and practice.

[27]  A. J. Man in 't Veld,et al.  Recurrence of hypertension in primary aldosteronism after discontinuation of spironolactone. Time course of changes in cardiac output and body fluid volumes. , 1982, Clinical and experimental hypertension. Part A, Theory and practice.

[28]  T. Philipp,et al.  Studies on the mechanism of mineralocorticoid-induced blood pressure increase in man. , 1979, Clinical science.